𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma

✍ Scribed by P. L. Zinzani; C. Baccini; A. Zaccaria; G. Visani; M. Buzzi; A. Morelli; A. L. Molinari; M. Salvucci; M. Bendandi; D. Rubboli; F. Gherlinzoni; R. Zanchini; S. Tura

Book ID
114792166
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
551 KB
Volume
57
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Elevated serum level of soluble CD23 pre
Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected rhesus monkeys
✍ Horst Hannig; Christian Buske; Kerstin MΓ€tz-Rensing; Gerhard Hunsmann; Wolfgang πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 193 KB πŸ‘ 1 views

Patients with HIV infection are at high risk for the development of high-grade B-non-Hodgkin's lymphoma (B-NHL). The aim of this study was identification of a predictive diagnostic marker for HIV-associated B-cell lymphomas, using simian-immunodeficiency-virus (SIV)-infected Rhesus monkeys as a well

Prognosis in low grade non-Hodgkin's lym
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level
✍ Dr. D. Parker; D. L. Alison; D. L. Barnard; J. A. Child; G. Dovey; J. Farish; D. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 760 KB

## Abstract Eighty‐eight patients with low grade non‐Hodgkin's lymphoma were followed for a median period of 63 months. Sixty‐eight per cent of the group were centrocytic/centroblastic B cell lymphomas by the updated Kiel classification. Fifty‐one (58 per cent) of the patients were stage IV by the